Mirostipen

DB06453ExperimentalSmall molecule

Investigated for use/treatment in breast cancer, lung cancer, and ovarian cancer.

Primary indication
Investigated for use/treatment in breast cancer, lung cancer, and ovarian cancer.Curator reviewed

Resolves to

Compound
UNIIOF5C04223VCAS244130-01-6

Which companies are running trials of Mirostipen, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In